Reuters: Pharmaceutical companies, WHO help India in HIV/AIDS drug crisis
“Indian companies and global health groups are stepping up efforts to provide a critical medicine for the country’s free HIV/AIDS drugs program after more than 150,000 patients risked going without their dosages this month. Delayed tender approvals and poor coordination with states left the National AIDS Control Organisation (NACO) scrambling for supplies. Reuters reported on Oct. 1 that the supplies were due to run out next week…” (Kalra, 10/13).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.